Notably, zinc pyrithione (ZnPT) targets SDCBP, restoring YAP1 degradation and suppressing tumour growth in PDX and PDO models, indicating the SDCBP–YAP1 axis as a promising therapeutic target for pancreatic cancer. The gene discussed is YAP1; the disease is familial pancreatic carcinoma.